Minims Phenylephrinhydrochlorid Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine hydrochloride acts as an alpha‑1 adrenergic receptor agonist on the smooth muscle of conjunctival blood vessels. Stimulation of these receptors causes vasoconstriction, which reduces blood flow to the ocular surface and diminishes the visible redness associated with hyperemia.

The specific dosing regimen is determined by the prescribing clinician. Typically, one drop is instilled in the affected eye(s) and may be repeated according to the healthcare professional’s instructions, not exceeding the recommended frequency.

Safety data for phenylephrine hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Phenylephrine hydrochloride is a sympathomimetic vasoconstrictor, similar in effect to agents such as naphazoline or tetrahydrozoline. Compared with those alternatives, phenylephrine typically has a rapid onset and a short duration of action, but individual response and tolerability may vary.

Store the eye‑drop bottle at room temperature, away from direct sunlight and moisture. Keep it in the original packaging to protect the solution from contamination. Do not freeze the product, and discard any solution that appears discolored or contains particles.

The product is applied topically to the eye. After washing hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill the prescribed number of drops. Close the eye gently for a few seconds and avoid blinking excessively to allow absorption.

Serious risks, though rare, include severe allergic reactions such as angioedema or anaphylaxis, a sudden increase in intra‑ocular pressure, and corneal edema. Patients should seek immediate medical attention if they experience intense eye pain, vision changes, or systemic allergic symptoms.

Individuals with known hypersensitivity to phenylephrine or any component of the formulation should avoid use. Patients with narrow‑angle or uncontrolled glaucoma, and those taking monoamine oxidase inhibitors or other systemic sympathomimetics, should consult a healthcare professional before using the product.